1 – 11 of 11
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2006
-
Mark
Predictors of lung function and its decline in mild to moderate COPD in association with gender: Results from the Euroscop study
(
- Contribution to journal › Article
- 2005
-
Mark
Effect of treatments on the progression of COPD: report of a workshop held in Leuven, 11-12 March 2004
(
- Contribution to journal › Scientific review
-
Mark
Cost-effectiveness of formoterol and salbutamol as asthma reliever medication in Sweden and in Spain.
(
- Contribution to journal › Article
- 2004
-
Mark
COPD exacerbations: the importance of a standard definition
(
- Contribution to journal › Article
- 2002
-
Mark
Bone mineral density in patients with chronic obstructive pulmonary disease treated with budesonide Turbuhaler.
(
- Contribution to journal › Article
- 2001
-
Mark
Adding formoterol to budesonide in moderate asthmatics is cost saving - Results from the FACET Study
(
- Contribution to journal › Article
-
Mark
Adding formoterol to budesonide in moderate asthma--health economic results from the FACET study
(
- Contribution to journal › Article
- 1999
-
Mark
Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease
(
- Contribution to journal › Article
-
Mark
Exacerbations of asthma: a descriptive study of 425 severe exacerbations. The FACET International Study Group
(
- Contribution to journal › Article
-
Mark
Asthma quality of life during 1 year of treatment with budesonide with or without formoterol
(
- Contribution to journal › Article
- 1998
-
Mark
The European Respiratory Society study on chronic obstructive pulmonary disease (EUROSCOP): recruitment methods and strategies
(
- Contribution to journal › Article